Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CIRH1A |
| Upstream (Parents) |
|---|
| (<<) CDK4 → CIRH1A |
| (<<) CYP2U1 → CIRH1A |
| (<<) ELK3 → CIRH1A |
| (<<) ENO1 → CIRH1A |
| (<<) LYAR → CIRH1A |
| (<<) MAPKAPK5 → CIRH1A |
| (<<) NFATC3 → CIRH1A |
| (<<) NFIX → CIRH1A |
| (<<) NR3C1 → CIRH1A |
| (<<) PPIF → CIRH1A |
| (<<) RRP1 → CIRH1A |
| (<<) SMURF1 → CIRH1A |
| (<<) TM4SF1 → CIRH1A |
| Downstream (Children) |
|---|
| CIRH1A → ABCF1 (>>) |
| CIRH1A → ATIC (>>) |
| CIRH1A → ATP2B1 (>>) |
| CIRH1A → CD3EAP (>>) |
| CIRH1A → CDH3 (>>) |
| CIRH1A → CTPS (>>) |
| CIRH1A → DNM2 (>>) |
| CIRH1A → EIF6 (>>) |
| CIRH1A → EPHB3 (>>) |
| CIRH1A → FAM110C (>>) |
| CIRH1A → GAL (>>) |
| CIRH1A → GNG10 (>>) |
| CIRH1A → GOT2 (>>) |
| CIRH1A → ITGA6 (>>) |
| CIRH1A → JMJD6 (>>) |
| CIRH1A → KCNN4 (>>) |
| CIRH1A → LIG1 (>>) |
| CIRH1A → LRP5 (>>) |
| CIRH1A → LYNX1 (>>) |
| CIRH1A → MAPK9 (>>) |
| CIRH1A → MEF2D (>>) |
| CIRH1A → NOL9 (>>) |
| CIRH1A → PFDN2 (>>) |
| CIRH1A → RARA (>>) |
| CIRH1A → RRP9 (>>) |
| CIRH1A → SEH1L (>>) |
| CIRH1A → SIN3A (>>) |
| CIRH1A → SLC16A6 (>>) |
| CIRH1A → SOD2 (>>) |
| CIRH1A → THOC4 (>>) |
| CIRH1A → TMEM87B (>>) |
| CIRH1A → TRERF1 (>>) |
| CIRH1A → TUBA1C (>>) |
